世界の肺炎検査市場2023年〜2027年

◆英語タイトル:Global Pneumonia Testing Market 2023-2027

Technavioが発行した調査報告書(IRTNTR74932-23)◆商品コード:IRTNTR74932-23
◆発行会社(リサーチ会社):Technavio
◆発行日:2023年1月31日
◆ページ数:約120
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:北米、ヨーロッパ、アジア、その他地域
◆産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD2,500 ⇒換算¥380,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD4,000 ⇒換算¥608,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行・送付致します。(請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

テックナビオ社の本調査資料では、世界の肺炎検査市場規模が2023年から2027年の間に709百万ドルに到達し、予測期間中の年平均成長率は5.3%になると展望しています。本書は、肺炎検査の世界市場について徹底的に調査し、市場の現状や動向をまとめた資料です。エグゼクティブサマリー、市場状況、市場規模予測、過去の市場規模、ファイブフォース分析、製品別(消耗品、アナライザ)分析、方法別(免疫診断、分子診断)分析、顧客状況、地域別(北米、ヨーロッパ、アジア、アメリカ、中国、ドイツ、イギリス、日本、その他地域)分析、企業分析などを整理しています。本資料内には、Abbott Laboratories、Acumen Diagnostics Pte Ltd.、Becton Dickinson and Co.、bioMerieux SA、Bio Rad Laboratories Inc.、Danaher Corp.、Diamedica SIA、Hologic Inc.、Laboratory Corp. of America Holdings、LGC Group、Meridian Bioscience Inc.、OpGen Inc.、Pfizer Inc.、Quest Diagnostics Inc.、Quidel Corp.、Thermo Fisher Scientific Inc.、Trinity Biotech Plc、Siemens AG、F. Hoffmann La Roche Ltd.、DiaSorin SpAXなどの企業情報が含まれています。
・エグゼクティブサマリー
・市場状況
・市場規模予測
・過去の市場規模
・ファイブフォース分析
・世界の肺炎検査市場規模:製品別
- 消耗品の市場規模
- アナライザの市場規模
・世界の肺炎検査市場規模:方法別
- 免疫診断における市場規模
- 分子診断における市場規模
・顧客状況
・世界の肺炎検査市場規模:地域別
- 北米の肺炎検査市場規模
- ヨーロッパの肺炎検査市場規模
- アジアの肺炎検査市場規模
- アメリカの肺炎検査市場規模
- 中国の肺炎検査市場規模
- ドイツの肺炎検査市場規模
- イギリスの肺炎検査市場規模
- 日本の肺炎検査市場規模
- その他地域の肺炎検査市場規模
・成長要因・課題・動向
・企業状況
・企業分析

テックナビオ社は、利益、価格、競争、プロモーションなどの主要なパラメーターを調査・分析することで、また様々なソースからのデータを調査、統合、および合計することにより、肺炎検査市場の詳しい全体像を示します。主な産業のインフルエンサーを特定することにより、市場の多様な側面を提示します。提示されたデータは包括的​​かつ信頼性があり、一次/二次の広範囲な調査の結果です。 テックナビオ社の市場調査資料は、正確な肺炎検査市場の成長を予想するための定性的および定量的調査を使用し、完全な競争状況と詳細なベンダー選択方法、また分析を整理しています。

肺炎検査の世界市場 2023-2027

Technavio社は、肺炎検査市場をモニターしており、2022年から2027年にかけて709百万ドルの成長が予測され、予測期間中のCAGRは5.3%で加速すると予測しています。当レポートでは、肺炎検査市場の全体的な分析、市場規模と予測、動向、成長促進要因、課題に加え、約25のベンダーを網羅したベンダー分析も提供しています。

当レポートでは、現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。市場を牽引するのは、肺炎の有病率の上昇と肺炎死亡率に関連する懸念、肺炎検出のための高度なマルチプレックスpcの開発、高齢者人口の増加です。

Technavioの肺炎検査市場は以下のように区分されます:

・製品タイプ別:
– 消耗品
– 分析装置

・検査法別:
– 免疫診断
– 分子診断
– ポイントオブケア検査

・地域別:
– 北米
– ヨーロッパ
– アジア
– その他の地域(ROW)

本調査では、今後数年間の肺炎検査市場の成長を促進する主な理由の一つとして、プロモーション活動の重要性の高まりを挙げています。また、新たな疾患ターゲットの出現、M&Aや新製品の上市数の増加が市場の大きな需要につながるとしています。

Technavio社は、主要パラメータの分析による複数の情報源からのデータの調査、統合、集計の方法により、市場の詳細な姿を提示します。

当レポートでは、肺炎検査市場について以下の分野をカバーしています:
– 肺炎検査市場の規模
– 肺炎検査市場予測
– 肺炎検査市場の産業分析

Technavio社の確実なベンダー分析は、クライアントが市場でのポジションを向上できるように設計されており、これに沿って本レポートには、Abbott Laboratories, Acumen Diagnostics Pte Ltd., Becton Dickinson and Co., bioMerieux SA, Bio Rad Laboratories Inc., Danaher Corp., Diamedica SIA, Hologic Inc., Laboratory Corp. of America Holdings, LGC Group, Meridian Bioscience Inc., OpGen Inc., Pfizer Inc., Quest Diagnostics Inc., Quidel Corp., Thermo Fisher Scientific Inc., Trinity Biotech Plc, Siemens AG, F. Hoffmann La Roche Ltd., and DiaSorin SpAなどの企業情報が含まれています。また、肺炎検査市場の分析レポートには、市場成長に影響を与える今後の動向や課題に関する情報も含まれています。これは、企業が戦略を立て、来るべき成長機会をすべて活用するのに役立つものです。

本調査は、業界の主要参加者からのインプットを含め、一次情報と二次情報を客観的に組み合わせて実施しました。本レポートでは、主要ベンダーの分析に加え、包括的な市場およびベンダーの状況を掲載しています。

Technavioは、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数の情報源からのデータを調査、統合、要約する方法で、市場の詳細な姿を提示します。また、主要な業界インフルエンサーを特定することで、市場の様々な側面を提示します。提示されるデータは包括的で信頼性が高く、一次および二次にわたる広範な調査の結果です。Technavioの市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、質的・量的調査を用いた綿密なベンダー選定方法と分析を提供します。

❖ レポートの目次 ❖

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary – Chart on Market Overview
o Exhibit 02: Executive Summary – Data Table on Market Overview
o Exhibit 03: Executive Summary – Chart on Global Market Characteristics
o Exhibit 04: Executive Summary – Chart on Market by Geography
o Exhibit 05: Executive Summary – Chart on Market Segmentation by Product Type
o Exhibit 06: Executive Summary – Chart on Market Segmentation by Method
o Exhibit 07: Executive Summary – Chart on Incremental Growth
o Exhibit 08: Executive Summary – Data Table on Incremental Growth
o Exhibit 09: Executive Summary – Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2022
o 3.4 Market outlook: Forecast for 2022-2027
o Exhibit 14: Chart on Global – Market size and forecast 2022-2027 ($ million)
o Exhibit 15: Data Table on Global – Market size and forecast 2022-2027 ($ million)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
• 4 Historic Market Size
o 4.1 Global pneumonia testing market 2017 – 2021
o Exhibit 18: Historic Market Size – Data Table on Global pneumonia testing market 2017 – 2021 ($ million)
o 4.2 Product Type Segment Analysis 2017 – 2021
o Exhibit 19: Historic Market Size – Product Type Segment 2017 – 2021 ($ million)
o 4.3 Method Segment Analysis 2017 – 2021
o Exhibit 20: Historic Market Size – Method Segment 2017 – 2021 ($ million)
o 4.4 Geography Segment Analysis 2017 – 2021
o Exhibit 21: Historic Market Size – Geography Segment 2017 – 2021 ($ million)
o 4.5 Country Segment Analysis 2017 – 2021
o Exhibit 22: Historic Market Size – Country Segment 2017 – 2021 ($ million)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis – Comparison between 2022 and 2027
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027
o 5.7 Market condition
o Exhibit 29: Chart on Market condition – Five forces 2022 and 2027
• 6 Market Segmentation by Product Type
o 6.1 Market segments
o Exhibit 30: Chart on Product Type – Market share 2022-2027 (%)
o Exhibit 31: Data Table on Product Type – Market share 2022-2027 (%)
o 6.2 Comparison by Product Type
o Exhibit 32: Chart on Comparison by Product Type
o Exhibit 33: Data Table on Comparison by Product Type
o 6.3 Consumables – Market size and forecast 2022-2027
o Exhibit 34: Chart on Consumables – Market size and forecast 2022-2027 ($ million)
o Exhibit 35: Data Table on Consumables – Market size and forecast 2022-2027 ($ million)
o Exhibit 36: Chart on Consumables – Year-over-year growth 2022-2027 (%)
o Exhibit 37: Data Table on Consumables – Year-over-year growth 2022-2027 (%)
o 6.4 Analyzers – Market size and forecast 2022-2027
o Exhibit 38: Chart on Analyzers – Market size and forecast 2022-2027 ($ million)
o Exhibit 39: Data Table on Analyzers – Market size and forecast 2022-2027 ($ million)
o Exhibit 40: Chart on Analyzers – Year-over-year growth 2022-2027 (%)
o Exhibit 41: Data Table on Analyzers – Year-over-year growth 2022-2027 (%)
o 6.5 Market opportunity by Product Type
o Exhibit 42: Market opportunity by Product Type ($ million)
• 7 Market Segmentation by Method
o 7.1 Market segments
o Exhibit 43: Chart on Method – Market share 2022-2027 (%)
o Exhibit 44: Data Table on Method – Market share 2022-2027 (%)
o 7.2 Comparison by Method
o Exhibit 45: Chart on Comparison by Method
o Exhibit 46: Data Table on Comparison by Method
o 7.3 Immunodiagnostics – Market size and forecast 2022-2027
o Exhibit 47: Chart on Immunodiagnostics – Market size and forecast 2022-2027 ($ million)
o Exhibit 48: Data Table on Immunodiagnostics – Market size and forecast 2022-2027 ($ million)
o Exhibit 49: Chart on Immunodiagnostics – Year-over-year growth 2022-2027 (%)
o Exhibit 50: Data Table on Immunodiagnostics – Year-over-year growth 2022-2027 (%)
o 7.4 Molecular diagnostics – Market size and forecast 2022-2027
o Exhibit 51: Chart on Molecular diagnostics – Market size and forecast 2022-2027 ($ million)
o Exhibit 52: Data Table on Molecular diagnostics – Market size and forecast 2022-2027 ($ million)
o Exhibit 53: Chart on Molecular diagnostics – Year-over-year growth 2022-2027 (%)
o Exhibit 54: Data Table on Molecular diagnostics – Year-over-year growth 2022-2027 (%)
o 7.5 Point-of-care testing – Market size and forecast 2022-2027
o Exhibit 55: Chart on Point-of-care testing – Market size and forecast 2022-2027 ($ million)
o Exhibit 56: Data Table on Point-of-care testing – Market size and forecast 2022-2027 ($ million)
o Exhibit 57: Chart on Point-of-care testing – Year-over-year growth 2022-2027 (%)
o Exhibit 58: Data Table on Point-of-care testing – Year-over-year growth 2022-2027 (%)
o 7.6 Market opportunity by Method
o Exhibit 59: Market opportunity by Method ($ million)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 60: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 61: Chart on Market share by geography 2022-2027 (%)
o Exhibit 62: Data Table on Market share by geography 2022-2027 (%)
o 9.2 Geographic comparison
o Exhibit 63: Chart on Geographic comparison
o Exhibit 64: Data Table on Geographic comparison
o 9.3 North America – Market size and forecast 2022-2027
o Exhibit 65: Chart on North America – Market size and forecast 2022-2027 ($ million)
o Exhibit 66: Data Table on North America – Market size and forecast 2022-2027 ($ million)
o Exhibit 67: Chart on North America – Year-over-year growth 2022-2027 (%)
o Exhibit 68: Data Table on North America – Year-over-year growth 2022-2027 (%)
o 9.4 Europe – Market size and forecast 2022-2027
o Exhibit 69: Chart on Europe – Market size and forecast 2022-2027 ($ million)
o Exhibit 70: Data Table on Europe – Market size and forecast 2022-2027 ($ million)
o Exhibit 71: Chart on Europe – Year-over-year growth 2022-2027 (%)
o Exhibit 72: Data Table on Europe – Year-over-year growth 2022-2027 (%)
o 9.5 Asia – Market size and forecast 2022-2027
o Exhibit 73: Chart on Asia – Market size and forecast 2022-2027 ($ million)
o Exhibit 74: Data Table on Asia – Market size and forecast 2022-2027 ($ million)
o Exhibit 75: Chart on Asia – Year-over-year growth 2022-2027 (%)
o Exhibit 76: Data Table on Asia – Year-over-year growth 2022-2027 (%)
o 9.6 Rest of World (ROW) – Market size and forecast 2022-2027
o Exhibit 77: Chart on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
o Exhibit 78: Data Table on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
o Exhibit 79: Chart on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
o Exhibit 80: Data Table on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
o 9.7 US – Market size and forecast 2022-2027
o Exhibit 81: Chart on US – Market size and forecast 2022-2027 ($ million)
o Exhibit 82: Data Table on US – Market size and forecast 2022-2027 ($ million)
o Exhibit 83: Chart on US – Year-over-year growth 2022-2027 (%)
o Exhibit 84: Data Table on US – Year-over-year growth 2022-2027 (%)
o 9.8 China – Market size and forecast 2022-2027
o Exhibit 85: Chart on China – Market size and forecast 2022-2027 ($ million)
o Exhibit 86: Data Table on China – Market size and forecast 2022-2027 ($ million)
o Exhibit 87: Chart on China – Year-over-year growth 2022-2027 (%)
o Exhibit 88: Data Table on China – Year-over-year growth 2022-2027 (%)
o 9.9 Germany – Market size and forecast 2022-2027
o Exhibit 89: Chart on Germany – Market size and forecast 2022-2027 ($ million)
o Exhibit 90: Data Table on Germany – Market size and forecast 2022-2027 ($ million)
o Exhibit 91: Chart on Germany – Year-over-year growth 2022-2027 (%)
o Exhibit 92: Data Table on Germany – Year-over-year growth 2022-2027 (%)
o 9.10 UK – Market size and forecast 2022-2027
o Exhibit 93: Chart on UK – Market size and forecast 2022-2027 ($ million)
o Exhibit 94: Data Table on UK – Market size and forecast 2022-2027 ($ million)
o Exhibit 95: Chart on UK – Year-over-year growth 2022-2027 (%)
o Exhibit 96: Data Table on UK – Year-over-year growth 2022-2027 (%)
o 9.11 Japan – Market size and forecast 2022-2027
o Exhibit 97: Chart on Japan – Market size and forecast 2022-2027 ($ million)
o Exhibit 98: Data Table on Japan – Market size and forecast 2022-2027 ($ million)
o Exhibit 99: Chart on Japan – Year-over-year growth 2022-2027 (%)
o Exhibit 100: Data Table on Japan – Year-over-year growth 2022-2027 (%)
o 9.12 Market opportunity by geography
o Exhibit 101: Market opportunity by geography ($ million)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 102: Impact of drivers and challenges in 2022 and 2027
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 103: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 104: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 105: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 106: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 107: Matrix on vendor position and classification
o 12.3 Abbott Laboratories
o Exhibit 108: Abbott Laboratories – Overview
o Exhibit 109: Abbott Laboratories – Business segments
o Exhibit 110: Abbott Laboratories – Key news
o Exhibit 111: Abbott Laboratories – Key offerings
o Exhibit 112: Abbott Laboratories – Segment focus
o 12.4 Becton Dickinson and Co.
o Exhibit 113: Becton Dickinson and Co. – Overview
o Exhibit 114: Becton Dickinson and Co. – Business segments
o Exhibit 115: Becton Dickinson and Co. – Key news
o Exhibit 116: Becton Dickinson and Co. – Key offerings
o Exhibit 117: Becton Dickinson and Co. – Segment focus
o 12.5 bioMerieux SA
o Exhibit 118: bioMerieux SA – Overview
o Exhibit 119: bioMerieux SA – Business segments
o Exhibit 120: bioMerieux SA – Key offerings
o Exhibit 121: bioMerieux SA – Segment focus
o 12.6 Bio Rad Laboratories Inc.
o Exhibit 122: Bio Rad Laboratories Inc. – Overview
o Exhibit 123: Bio Rad Laboratories Inc. – Business segments
o Exhibit 124: Bio Rad Laboratories Inc. – Key news
o Exhibit 125: Bio Rad Laboratories Inc. – Key offerings
o Exhibit 126: Bio Rad Laboratories Inc. – Segment focus
o 12.7 Danaher Corp.
o Exhibit 127: Danaher Corp. – Overview
o Exhibit 128: Danaher Corp. – Business segments
o Exhibit 129: Danaher Corp. – Key news
o Exhibit 130: Danaher Corp. – Key offerings
o Exhibit 131: Danaher Corp. – Segment focus
o 12.8 DiaSorin SpA
o Exhibit 132: DiaSorin SpA – Overview
o Exhibit 133: DiaSorin SpA – Business segments
o Exhibit 134: DiaSorin SpA – Key news
o Exhibit 135: DiaSorin SpA – Key offerings
o Exhibit 136: DiaSorin SpA – Segment focus
o 12.9 F. Hoffmann La Roche Ltd.
o Exhibit 137: F. Hoffmann La Roche Ltd. – Overview
o Exhibit 138: F. Hoffmann La Roche Ltd. – Business segments
o Exhibit 139: F. Hoffmann La Roche Ltd. – Key news
o Exhibit 140: F. Hoffmann La Roche Ltd. – Key offerings
o Exhibit 141: F. Hoffmann La Roche Ltd. – Segment focus
o 12.10 Hologic Inc.
o Exhibit 142: Hologic Inc. – Overview
o Exhibit 143: Hologic Inc. – Business segments
o Exhibit 144: Hologic Inc. – Key news
o Exhibit 145: Hologic Inc. – Key offerings
o Exhibit 146: Hologic Inc. – Segment focus
o 12.11 Laboratory Corp. of America Holdings
o Exhibit 147: Laboratory Corp. of America Holdings – Overview
o Exhibit 148: Laboratory Corp. of America Holdings – Business segments
o Exhibit 149: Laboratory Corp. of America Holdings – Key news
o Exhibit 150: Laboratory Corp. of America Holdings – Key offerings
o Exhibit 151: Laboratory Corp. of America Holdings – Segment focus
o 12.12 Meridian Bioscience Inc.
o Exhibit 152: Meridian Bioscience Inc. – Overview
o Exhibit 153: Meridian Bioscience Inc. – Business segments
o Exhibit 154: Meridian Bioscience Inc. – Key offerings
o Exhibit 155: Meridian Bioscience Inc. – Segment focus
o 12.13 OpGen Inc.
o Exhibit 156: OpGen Inc. – Overview
o Exhibit 157: OpGen Inc. – Product / Service
o Exhibit 158: OpGen Inc. – Key offerings
o 12.14 Pfizer Inc.
o Exhibit 159: Pfizer Inc. – Overview
o Exhibit 160: Pfizer Inc. – Product / Service
o Exhibit 161: Pfizer Inc. – Key news
o Exhibit 162: Pfizer Inc. – Key offerings
o 12.15 Quest Diagnostics Inc.
o Exhibit 163: Quest Diagnostics Inc. – Overview
o Exhibit 164: Quest Diagnostics Inc. – Business segments
o Exhibit 165: Quest Diagnostics Inc. – Key offerings
o Exhibit 166: Quest Diagnostics Inc. – Segment focus
o 12.16 Quidel Corp.
o Exhibit 167: Quidel Corp. – Overview
o Exhibit 168: Quidel Corp. – Product / Service
o Exhibit 169: Quidel Corp. – Key offerings
o 12.17 Siemens AG
o Exhibit 170: Siemens AG – Overview
o Exhibit 171: Siemens AG – Business segments
o Exhibit 172: Siemens AG – Key news
o Exhibit 173: Siemens AG – Key offerings
o Exhibit 174: Siemens AG – Segment focus
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 175: Inclusions checklist
o Exhibit 176: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 177: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 178: Research methodology
o Exhibit 179: Validation techniques employed for market sizing
o Exhibit 180: Information sources
o 13.5 List of abbreviations
o Exhibit 181: List of abbreviations

Exhibits:
Exhibits1: Executive Summary – Chart on Market Overview
Exhibits2: Executive Summary – Data Table on Market Overview
Exhibits3: Executive Summary – Chart on Global Market Characteristics
Exhibits4: Executive Summary – Chart on Market by Geography
Exhibits5: Executive Summary – Chart on Market Segmentation by Product Type
Exhibits6: Executive Summary – Chart on Market Segmentation by Method
Exhibits7: Executive Summary – Chart on Incremental Growth
Exhibits8: Executive Summary – Data Table on Incremental Growth
Exhibits9: Executive Summary – Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global – Market size and forecast 2022-2027 ($ million)
Exhibits15: Data Table on Global – Market size and forecast 2022-2027 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size – Data Table on Global pneumonia testing market 2017 – 2021 ($ million)
Exhibits19: Historic Market Size – Product Type Segment 2017 – 2021 ($ million)
Exhibits20: Historic Market Size – Method Segment 2017 – 2021 ($ million)
Exhibits21: Historic Market Size – Geography Segment 2017 – 2021 ($ million)
Exhibits22: Historic Market Size – Country Segment 2017 – 2021 ($ million)
Exhibits23: Five forces analysis – Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants – Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes – Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry – Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition – Five forces 2022 and 2027
Exhibits30: Chart on Product Type – Market share 2022-2027 (%)
Exhibits31: Data Table on Product Type – Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by Product Type
Exhibits33: Data Table on Comparison by Product Type
Exhibits34: Chart on Consumables – Market size and forecast 2022-2027 ($ million)
Exhibits35: Data Table on Consumables – Market size and forecast 2022-2027 ($ million)
Exhibits36: Chart on Consumables – Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Consumables – Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on Analyzers – Market size and forecast 2022-2027 ($ million)
Exhibits39: Data Table on Analyzers – Market size and forecast 2022-2027 ($ million)
Exhibits40: Chart on Analyzers – Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on Analyzers – Year-over-year growth 2022-2027 (%)
Exhibits42: Market opportunity by Product Type ($ million)
Exhibits43: Chart on Method – Market share 2022-2027 (%)
Exhibits44: Data Table on Method – Market share 2022-2027 (%)
Exhibits45: Chart on Comparison by Method
Exhibits46: Data Table on Comparison by Method
Exhibits47: Chart on Immunodiagnostics – Market size and forecast 2022-2027 ($ million)
Exhibits48: Data Table on Immunodiagnostics – Market size and forecast 2022-2027 ($ million)
Exhibits49: Chart on Immunodiagnostics – Year-over-year growth 2022-2027 (%)
Exhibits50: Data Table on Immunodiagnostics – Year-over-year growth 2022-2027 (%)
Exhibits51: Chart on Molecular diagnostics – Market size and forecast 2022-2027 ($ million)
Exhibits52: Data Table on Molecular diagnostics – Market size and forecast 2022-2027 ($ million)
Exhibits53: Chart on Molecular diagnostics – Year-over-year growth 2022-2027 (%)
Exhibits54: Data Table on Molecular diagnostics – Year-over-year growth 2022-2027 (%)
Exhibits55: Chart on Point-of-care testing – Market size and forecast 2022-2027 ($ million)
Exhibits56: Data Table on Point-of-care testing – Market size and forecast 2022-2027 ($ million)
Exhibits57: Chart on Point-of-care testing – Year-over-year growth 2022-2027 (%)
Exhibits58: Data Table on Point-of-care testing – Year-over-year growth 2022-2027 (%)
Exhibits59: Market opportunity by Method ($ million)
Exhibits60: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits61: Chart on Market share by geography 2022-2027 (%)
Exhibits62: Data Table on Market share by geography 2022-2027 (%)
Exhibits63: Chart on Geographic comparison
Exhibits64: Data Table on Geographic comparison
Exhibits65: Chart on North America – Market size and forecast 2022-2027 ($ million)
Exhibits66: Data Table on North America – Market size and forecast 2022-2027 ($ million)
Exhibits67: Chart on North America – Year-over-year growth 2022-2027 (%)
Exhibits68: Data Table on North America – Year-over-year growth 2022-2027 (%)
Exhibits69: Chart on Europe – Market size and forecast 2022-2027 ($ million)
Exhibits70: Data Table on Europe – Market size and forecast 2022-2027 ($ million)
Exhibits71: Chart on Europe – Year-over-year growth 2022-2027 (%)
Exhibits72: Data Table on Europe – Year-over-year growth 2022-2027 (%)
Exhibits73: Chart on Asia – Market size and forecast 2022-2027 ($ million)
Exhibits74: Data Table on Asia – Market size and forecast 2022-2027 ($ million)
Exhibits75: Chart on Asia – Year-over-year growth 2022-2027 (%)
Exhibits76: Data Table on Asia – Year-over-year growth 2022-2027 (%)
Exhibits77: Chart on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
Exhibits78: Data Table on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
Exhibits79: Chart on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
Exhibits80: Data Table on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
Exhibits81: Chart on US – Market size and forecast 2022-2027 ($ million)
Exhibits82: Data Table on US – Market size and forecast 2022-2027 ($ million)
Exhibits83: Chart on US – Year-over-year growth 2022-2027 (%)
Exhibits84: Data Table on US – Year-over-year growth 2022-2027 (%)
Exhibits85: Chart on China – Market size and forecast 2022-2027 ($ million)
Exhibits86: Data Table on China – Market size and forecast 2022-2027 ($ million)
Exhibits87: Chart on China – Year-over-year growth 2022-2027 (%)
Exhibits88: Data Table on China – Year-over-year growth 2022-2027 (%)
Exhibits89: Chart on Germany – Market size and forecast 2022-2027 ($ million)
Exhibits90: Data Table on Germany – Market size and forecast 2022-2027 ($ million)
Exhibits91: Chart on Germany – Year-over-year growth 2022-2027 (%)
Exhibits92: Data Table on Germany – Year-over-year growth 2022-2027 (%)
Exhibits93: Chart on UK – Market size and forecast 2022-2027 ($ million)
Exhibits94: Data Table on UK – Market size and forecast 2022-2027 ($ million)
Exhibits95: Chart on UK – Year-over-year growth 2022-2027 (%)
Exhibits96: Data Table on UK – Year-over-year growth 2022-2027 (%)
Exhibits97: Chart on Japan – Market size and forecast 2022-2027 ($ million)
Exhibits98: Data Table on Japan – Market size and forecast 2022-2027 ($ million)
Exhibits99: Chart on Japan – Year-over-year growth 2022-2027 (%)
Exhibits100: Data Table on Japan – Year-over-year growth 2022-2027 (%)
Exhibits101: Market opportunity by geography ($ million)
Exhibits102: Impact of drivers and challenges in 2022 and 2027
Exhibits103: Overview on Criticality of inputs and Factors of differentiation
Exhibits104: Overview on factors of disruption
Exhibits105: Impact of key risks on business
Exhibits106: Vendors covered
Exhibits107: Matrix on vendor position and classification
Exhibits108: Abbott Laboratories – Overview
Exhibits109: Abbott Laboratories – Business segments
Exhibits110: Abbott Laboratories – Key news
Exhibits111: Abbott Laboratories – Key offerings
Exhibits112: Abbott Laboratories – Segment focus
Exhibits113: Becton Dickinson and Co. – Overview
Exhibits114: Becton Dickinson and Co. – Business segments
Exhibits115: Becton Dickinson and Co. – Key news
Exhibits116: Becton Dickinson and Co. – Key offerings
Exhibits117: Becton Dickinson and Co. – Segment focus
Exhibits118: bioMerieux SA – Overview
Exhibits119: bioMerieux SA – Business segments
Exhibits120: bioMerieux SA – Key offerings
Exhibits121: bioMerieux SA – Segment focus
Exhibits122: Bio Rad Laboratories Inc. – Overview
Exhibits123: Bio Rad Laboratories Inc. – Business segments
Exhibits124: Bio Rad Laboratories Inc. – Key news
Exhibits125: Bio Rad Laboratories Inc. – Key offerings
Exhibits126: Bio Rad Laboratories Inc. – Segment focus
Exhibits127: Danaher Corp. – Overview
Exhibits128: Danaher Corp. – Business segments
Exhibits129: Danaher Corp. – Key news
Exhibits130: Danaher Corp. – Key offerings
Exhibits131: Danaher Corp. – Segment focus
Exhibits132: DiaSorin SpA – Overview
Exhibits133: DiaSorin SpA – Business segments
Exhibits134: DiaSorin SpA – Key news
Exhibits135: DiaSorin SpA – Key offerings
Exhibits136: DiaSorin SpA – Segment focus
Exhibits137: F. Hoffmann La Roche Ltd. – Overview
Exhibits138: F. Hoffmann La Roche Ltd. – Business segments
Exhibits139: F. Hoffmann La Roche Ltd. – Key news
Exhibits140: F. Hoffmann La Roche Ltd. – Key offerings
Exhibits141: F. Hoffmann La Roche Ltd. – Segment focus
Exhibits142: Hologic Inc. – Overview
Exhibits143: Hologic Inc. – Business segments
Exhibits144: Hologic Inc. – Key news
Exhibits145: Hologic Inc. – Key offerings
Exhibits146: Hologic Inc. – Segment focus
Exhibits147: Laboratory Corp. of America Holdings – Overview
Exhibits148: Laboratory Corp. of America Holdings – Business segments
Exhibits149: Laboratory Corp. of America Holdings – Key news
Exhibits150: Laboratory Corp. of America Holdings – Key offerings
Exhibits151: Laboratory Corp. of America Holdings – Segment focus
Exhibits152: Meridian Bioscience Inc. – Overview
Exhibits153: Meridian Bioscience Inc. – Business segments
Exhibits154: Meridian Bioscience Inc. – Key offerings
Exhibits155: Meridian Bioscience Inc. – Segment focus
Exhibits156: OpGen Inc. – Overview
Exhibits157: OpGen Inc. – Product / Service
Exhibits158: OpGen Inc. – Key offerings
Exhibits159: Pfizer Inc. – Overview
Exhibits160: Pfizer Inc. – Product / Service
Exhibits161: Pfizer Inc. – Key news
Exhibits162: Pfizer Inc. – Key offerings
Exhibits163: Quest Diagnostics Inc. – Overview
Exhibits164: Quest Diagnostics Inc. – Business segments
Exhibits165: Quest Diagnostics Inc. – Key offerings
Exhibits166: Quest Diagnostics Inc. – Segment focus
Exhibits167: Quidel Corp. – Overview
Exhibits168: Quidel Corp. – Product / Service
Exhibits169: Quidel Corp. – Key offerings
Exhibits170: Siemens AG – Overview
Exhibits171: Siemens AG – Business segments
Exhibits172: Siemens AG – Key news
Exhibits173: Siemens AG – Key offerings
Exhibits174: Siemens AG – Segment focus
Exhibits175: Inclusions checklist
Exhibits176: Exclusions checklist
Exhibits177: Currency conversion rates for US$
Exhibits178: Research methodology
Exhibits179: Validation techniques employed for market sizing
Exhibits180: Information sources
Exhibits181: List of abbreviations



❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の肺炎検査市場2023年〜2027年(Global Pneumonia Testing Market 2023-2027)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆